nygazet.com logo
Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal
business

Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal

•
1 min read
•
The New York Times

The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker of Ozempic and Wegovy.

The obesity drug developer Metsera said on Friday that it had agreed to a deal to be acquired by Pfizer, which had been locked in a bidding war for the company with Novo Nordisk, the Danish maker of the weight-loss treatments Ozempic and Wegovy. Pfiz... [1766 chars]

Read Original Article

Source: The New York Times

Visit Source

Share this article

TwitterFacebook
Back to business news